Clinical Stage I Gastric Cancer AJCC v8

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Clinical Stage I Gastric Cancer AJCC v8 trials may be worth asking about

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 1/2

NCT05269381

Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors

This phase I/II trial tests the safety and tolerability of an experimental personalized vaccine when given by itself and with pembrolizumab in treating patients…

United States132 participantsStarted 2022-03-31Updated 2026-06-23

Treatment: Cyclophosphamide, Neoantigen Peptide Vaccine

All recent trials (17 shown)

By InvitationPhase 2

NCT07139951

Hyperthermic Intraperitoneal Chemotherapy With Cisplatin and Paclitaxel for the Treatment of Gastric Cancer At High Risk…

This phase II trial tests how well concentrating heated (hyperthermic) chemotherapy in the area that contains the abdominal organs (intraperitoneal \[IP\]) at t…

United States16 participantsStarted 2025-12-03Updated 2026-06-17

Treatment: Biopsy Procedure, Biospecimen Collection

Active — Not RecruitingPhase 2

NCT05836584

Testing Immunotherapy (Atezolizumab) With or Without Chemotherapy in Locoregional MSI-H/dMMR Gastric and Gastroesophagea…

This phase II trial compares atezolizumab in combination with chemotherapy (docetaxel, oxaliplatin, leucovorin calcium, fluorouracil, capecitabine) to atezolizu…

United States240 participantsStarted 2023-12-06

Clinical Stage I Gastric Cancer AJCC v8

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors

All recent trials (17 shown)

Hyperthermic Intraperitoneal Chemotherapy With Cisplatin and Paclitaxel for the Treatment of Gastric Cancer At High Risk…

Testing Immunotherapy (Atezolizumab) With or Without Chemotherapy in Locoregional MSI-H/dMMR Gastric and Gastroesophagea…

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors

All recent trials (17 shown)

Hyperthermic Intraperitoneal Chemotherapy With Cisplatin and Paclitaxel for the Treatment of Gastric Cancer At High Risk…

Testing Immunotherapy (Atezolizumab) With or Without Chemotherapy in Locoregional MSI-H/dMMR Gastric and Gastroesophagea…

Futibatinib With Paclitaxel and Ramucirumab for the Treatment of Locally Advanced or Unresectable Gastric, Gastroesophag…

Individually Tailored, Supervised, Remote Exercise Intervention to Improve Physical Function for Stage I-III Gastroesoph…

Paclitaxel for the Treatment of Gastric or Gastroesophageal Cancer

Nivolumab, Ipilimumab and Chemoradiation in Treating Patients With Resectable Gastric Cancer

A Prospective Study of Physical Function in Adults Who Receive Systemic Therapy for Stage I-III Gastroesophageal Cancer,…

Sonidegib and Pembrolizumab in Treating Patients With Advanced Solid Tumors

Early Recovery After Surgery Protocol in Improving Quality of Life in Participants With Stage 0-IIIC Gastric Cancer Unde…

Short-Course Chemoradiotherapy Followed by Chemotherapy for the Treatment of Resectable Gastric Adenocarcinoma

Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes

A Vaccine (Ad5.F35-hGCC-PADRE) for the Treatment of Gastrointestinal Adenocarcinoma

Real-Time Monitoring of Chemotherapy Side-Effects in Patients With Gastrointestinal Cancers, RT-CAMSS Study

Neoadjuvant Therapy for the Treatment of Gastroesophageal Junction and Gastric Cancers

Testing the Addition of an Anticancer Drug, BAY 1895344, to the Usual Chemotherapy With FOLFIRI in Advanced or Metastati…

Clinical Trial to Evaluate the Efficacy and Safety of a Thoracic and Abdominal Endoscopic Surgical System